论文部分内容阅读
冠状动脉粥样硬化性心脏病患者以老年人居多,循证医学研究显示,冠状动脉粥样硬化性心脏病患者强化抗血小板治疗,心脏事件发生率会明显降低。现就老年冠状动脉粥样硬化性心脏病抗血小板治疗的临床现状做一综述。
Coronary atherosclerotic heart disease patients are mostly elderly, evidence-based medical research shows that patients with coronary atherosclerotic heart disease enhanced anti-platelet therapy, the incidence of cardiac events will be significantly reduced. Now on the elderly coronary atherosclerotic heart disease clinical review of antiplatelet therapy are reviewed.